Results 131 to 140 of about 2,316,210 (327)

On the stability of passive dynamic walker with flat foot and series ankle spring [PDF]

, 2018
Jiawei He, Gexue Ren
openalex   +1 more source

Static, dynamic and stability analysis of multi-dimensional functional graded plate with variable thickness using deep neural network [PDF]

, 2023
Nam G. Luu, Thanh T. Banh
openalex   +1 more source

Dinámica de la frecuencia del Sistema InterconectadDinámica Interconectado Ecuador-Colombia; Dinamic of the frequency of the interconected system Ecuador- Colombia

Revista Científica de Ingeniería Energética, 2011
En el presente trabajo se propone un procedimiento para estudiar la dinámica de lafrecuencia del sistema interconectado Ecuador-Colombia, ante la salida de unidadesgeneradoras cuando no se dispone de la información necesaria del sistema el ...
Marcelo Arias Castañeda, Antonio Martínez García   +1 more
doaj  

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Practical Stability of Dynamic Systems with Time Delays in Terms of Two Measurements [PDF]

, 2012
Chao Peng, Yu-Hua Yang, Y. Zhang
openalex   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Dynamic Radiographs in Assessing Stability of Cervical Spine Fractures: A Multicentre Study

, 2022
Ruben Patrick Thumbadoo, Jan Herzog, Niv Bhamber, Cristina Lupu, Kenny Kwan, Andrew Clarke, Michael Hutton, J Bernard, D. Timothy Bishop, Darren F. Lui   +9 more
openalex   +1 more source

Dynamic numerical-experimental analysis of the stability of prosthetic elements of total hip arthroplasty [PDF]

, 2023
Sareh HosseiniMarashi
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source